Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
56.1M
-
Number of holders
-
59
-
Total 13F shares, excl. options
-
6.15M
-
Shares change
-
+567K
-
Total reported value, excl. options
-
$33.8M
-
Value change
-
+$3.33M
-
Put/Call ratio
-
0.96
-
Number of buys
-
32
-
Number of sells
-
-17
-
Price
-
$5.50
Significant Holders of ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA) as of Q1 2023
74 filings reported holding ZVRA - ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of Q1 2023.
ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA) has 59 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.15M shares
of 56.1M outstanding shares and own 10.97% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1.47M shares), BlackRock Inc. (603K shares), Laurion Capital Management LP (571K shares), Janney Montgomery Scott LLC (529K shares), GREAT POINT PARTNERS LLC (348K shares), Retirement Planning Co of New England, Inc. (328K shares), GEODE CAPITAL MANAGEMENT, LLC (319K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (201K shares), JANE STREET GROUP, LLC (185K shares), and Mystic Asset Management, Inc. (178K shares).
This table shows the top 59 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.